Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • ckant
    Junior Member
    • Sep 2011
    • 5

    Differential expression using DGEseq

    First of all I am very new in this field. .
    I am having RPKM values of a set of genes, in 4 different samples. I want to use DEGseq for the differential expression analysis. I would like to know, how appropriate it will be, using DEGseq for RPKM values.
    Last edited by ckant; 12-12-2013, 11:24 PM.
  • dpryan
    Devon Ryan
    • Jul 2011
    • 3478

    #2
    Firstly, don't use DEGseq. DESeq2, edgeR, or limma (see the voom() function) would be more appropriate choices.

    Secondly, the ease with which one can convert between RPKM values and raw counts depends upon how the RPKM values were derived. In general, it's easier to just run featureCounts or htseq-count on the alignments and just be done with it

    Comment

    • sphil
      Senior Member
      • Apr 2010
      • 192

      #3
      Originally posted by dpryan View Post
      Firstly, don't use DEGseq. DESeq2, edgeR, or limma (see the voom() function) would be more appropriate choices.
      In general I would say you are right not using DEGSeq but has it lost it's permit to live / to be used at all? Can't there be a case where DEGSeq seems to model the data more accuaretly than DESeq2 or edgeR. Especially since both DESeq2 and edgeR are using NB Models and DEGSeq uses poisson?

      Comment

      • dpryan
        Devon Ryan
        • Jul 2011
        • 3478

        #4
        It's really a question of whether the Poisson model is ever more accurate than the NB model for biologically realistic RNAseq data. I'm sure there are circumstances where that's the case, but I suspect that they're exceedingly rare. If someone is asking about converting from RPKMs to counts, then they won't/shouldn't be working on one of these rare cases

        Comment

        • sphil
          Senior Member
          • Apr 2010
          • 192

          #5
          That's true! I general I'd say go with deseq2 / edgeR and there is litte that can go wrong.

          Comment

          • ckant
            Junior Member
            • Sep 2011
            • 5

            #6
            Thanks

            Thanks a lot for your nice suggestions, I am now using DESeq2, and its working !!!

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
              by SEQadmin2


              Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

              The systematic characterization of the human proteome has
              ...
              07-20-2026, 11:48 AM
            • SEQadmin2
              Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
              by SEQadmin2



              Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
              ...
              07-09-2026, 11:10 AM
            • SEQadmin2
              Cancer Drug Resistance: The Lingering Barrier to Rising Survival
              by SEQadmin2



              Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

              There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
              07-08-2026, 05:17 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, 07-24-2026, 12:17 PM
            0 responses
            15 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-23-2026, 11:41 AM
            0 responses
            15 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-20-2026, 11:10 AM
            0 responses
            23 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-13-2026, 10:26 AM
            0 responses
            37 views
            0 reactions
            Last Post SEQadmin2  
            Working...